Yong Yang

Title: Yong Yang: Innovator in Immunology

Introduction

Yong Yang is a prominent inventor based in Changchun, China. He has made significant contributions to the field of immunology, particularly in the development of diagnostic tools and vaccines. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

Yong Yang's latest patents include a B-cell epitope of cysteine protease inhibitor, a hybridoma cell line, and a monoclonal antibody. The first patent relates to a hybridoma cell line capable of generating the anti-WN10 antibody. This innovation identifies the specific B-cell epitope of the WN10 protein recognized by the monoclonal antibody. These advancements are crucial for diagnosing trichinellosis and establishing competitive ELISA for detecting antibodies and sandwich ELISA for detecting circulating antigens. The second patent focuses on a hybridoma cell strain and a monoclonal antibody secreted from it, aimed at diagnosing trichinellosis specifically. The hybridoma cell strain is deposited under the accession number CGMCC No. 18317. Tests have shown that the monoclonal antibody Ts-ZH68-2A4-Ab can compete with the positive serum of pigs infected with the target antigen, Ts-ZH68.

Career Highlights

Yong Yang is affiliated with Jilin University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to immunological challenges.

Collaborations

Yong Yang collaborates with notable colleagues, including Xiaolei Liu and Mingyuan Liu, to further advance his research in immunology.

Conclusion

Yong Yang's contributions to immunology through his patents and research at Jilin University highlight his role as an influential inventor in the field. His work is paving the way for improved diagnostic methods and potential vaccines, which could significantly benefit public health.